Corcept Therapeutics Inc
CORT
$72.27+0.93 (+1.30%)
Jul 5, 2025, 4:00 PM
Financials
52Week High | 117.33 | 52Week Low | 29.42 |
Beta | 0.30 | Current Ratio Annual | 3.35 |
Current Ratio Quarterly | 3.07 | Gross Margin TTM | 98.43 |
Market Cap | 7.66B | Net Profit Margin TTM | 19.55 |
Operating Margin TTM | 16.17 | Price To Book | 11.22 |
Price To Earnings TTM | 57.20 | Price To Free Cash Flow TTM | 43.26 |
Price To Sales TTM | 11.18 | Quick Ratio Annual | 3.19 |
Quick Ratio Quarterly | 2.90 | Return On Assets TTM | 16.82 |
Return On Equity TTM | 20.63 | Return On Investment TTM | 20.63 |
Revenue Growth3Y | 22.64 | Revenue Growth5Y | 17.11 |
Revenue Growth Quarterly Yoy | 7.09 | Revenue Growth TTMYoy | 30.93 |
Revenue Per Share TTM | 5.72 |
Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 418 | 103 | 51 | 128 | 140 | 41 | 86.66M | $8.53B |
Jun 30, 2025 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | $0 |
Change | 418(100%) | 103(100%) | 51(100%) | 128(100%) | 140(100%) | 41(100%) | 86.66M(100%) | $8.53B(100%) |